The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential mutation profiles between benign and cancerous urothelium in patients with non-muscle invasive bladder cancer (NMIBC).
 
Hiroko Miyagi
No Relationships to Disclose
 
Joshua Linscott
No Relationships to Disclose
 
Billie Gould
No Relationships to Disclose
 
Prithvi Murthy
No Relationships to Disclose
 
Pan Du
Employment - Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
 
Shidong Jia
Employment - Genentech (I); Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
Patents, Royalties, Other Intellectual Property - Liquid biopsy in cancer detection, therapy monitoring, MRD and early cancer detection
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; crispr therapeutics; Editas Medicine; Guardant Health; Intellia Therapeutics; Lilly
Consulting or Advisory Role - Arquer Diagnostics; Bristol-Myers Squibb; CG Oncology; FerGene; Ferring; Lucence Diagnostics; Merck; Urogen pharma
Research Funding - CG Oncology; Predicine
Expert Testimony - CG Oncology
Travel, Accommodations, Expenses - CG Oncology
Other Relationship - Predicine